Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3175 USD
−21.27 M USD
0.00 USD
29.57 M
About Coeptis Therapeutics Holdings, Inc.
Sector
Industry
CEO
David Mehalick
Website
Headquarters
Wexford
Founded
2017
FIGI
BBG00XTTT1C5
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of COEP is 0.1420 USD — it has increased by 1.72% in the past 24 hours. Watch Coeptis Therapeutics Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Coeptis Therapeutics Holdings, Inc. stocks are traded under the ticker COEP.
COEP stock has fallen by −27.18% compared to the previous week, the month change is a −25.26% fall, over the last year Coeptis Therapeutics Holdings, Inc. has showed a −83.86% decrease.
COEP reached its all-time high on Oct 28, 2022 with the price of 21.4200 USD, and its all-time low was 0.1311 USD and was reached on Dec 19, 2024. View more price dynamics on COEP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COEP stock is 6.67% volatile and has beta coefficient of 1.55. Track Coeptis Therapeutics Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Coeptis Therapeutics Holdings, Inc. there?
Today Coeptis Therapeutics Holdings, Inc. has the market capitalization of 5.84 M, it has decreased by −33.84% over the last week.
Yes, you can track Coeptis Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Coeptis Therapeutics Holdings, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
COEP net income for the last quarter is −1.83 M USD, while the quarter before that showed −3.04 M USD of net income which accounts for 39.75% change. Track more Coeptis Therapeutics Holdings, Inc. financial stats to get the full picture.
No, COEP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 7.00 employees. See our rating of the largest employees — is Coeptis Therapeutics Holdings, Inc. on this list?
Like other stocks, COEP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Coeptis Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Coeptis Therapeutics Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Coeptis Therapeutics Holdings, Inc. stock shows the sell signal. See more of Coeptis Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.